A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: HIV-1 uses cellular co-factors for virion formation and release. The virus is able to incorporate into the viral particles host cellular proteins, such as tetraspanins which could serve to facilitate HIV-1 egress. Here, we investigated the implication of several tetraspanins on HIV-1 formation and release in chronically infected T-lymphoblastic cells, a model that permits the study of the late steps of HIV-1 replication. Results: Our data revealed that HIV-1 Gag and Env structural proteins co-localized with tetraspanins in the form of clusters. Co-immunoprecipitation experiments showed that Gag proteins interact, directly or indirectly, with CD81, and less with CD82, in tetraspanin-enriched microdomains composed of CD81/CD82/CD63. In addition, when HIV-1 producing cells were treated with anti-CD81 antibodies, or upon CD81 silencing by RNA interference, HIV-1 release was significantly impaired, and its infectivity was modulated. Finally, CD81 downregulation resulted in Gag redistribution at the cell surface. Conclusion: Our findings not only extend the notion that HIV-1 assembly can occur on tetraspanin-enriched microdomains in T cells, but also highlight a critical role for the tetraspanin CD81 on the late steps of HIV replication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
B lymphocytes secrete antigen-presenting vesicles.
Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., & Geuze, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1161 · Cited by 3,546 · cited 2×
“Tetraspanins can be found at the cell surface and in intracellular compartments: CD63, which possesses an interacting motif with the adaptor AP-3 protein, is mainly targeted to the endocytic pathway [24] while most of the other tetraspanins are found both at the plasma membrane and in intracellular vesicles [25].”
Naldini, L., Blömer, U., Gage, F. H., Trono, D., & Verma, I. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11382 · Cited by 1,499 · cited 2×
“CD81 silencing using lentivectors and infectivity Lentivectors were produced as follow: 293T cells were transfected with the plasmids expressing the envelope VSV-G, the HIV-1 Gag-Pol [34] and the shRNA directed against CD81 (UCAUGAUGUUCGUUGGCU) or the control shRNA (GACCCCCUUGTGAAUCUC).”
Escola, J.-M., Kleijmeer, M. J., Stoorvogel, W., Griffith, J. M., Yoshie, O., & Geuze, H. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20121 · Cited by 1,228
Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane
Ono, A., Ablan, S. D., Lockett, S. J., Nagashima, K., & Freed, E. O. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405596101 · Cited by 553
Quantitation of human immunodeficiency virus type 1 infection kinetics
Dimitrov, D. S., Willey, R. L., Sato, H., Chang, L. J., Blumenthal, R., & Martin, M. A. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.2182-2190.1993 · Cited by 515 · cited 1×
“What can differ between the VCC and the LE/MVB is the lack of acidification, permitting the persistence of infectious HIV-1 particles within cells for a long time [51,33,17].”
Chertova, E., Chertov, O., Coren, L. V., Roser, J. D., Trubey, C. M., Bess, J. W., Sowder, R. C., Barsov, E., Hood, B. L., Fisher, R. J., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01013-06 · Cited by 462 · cited 3×
“CD45, which is an abundant cell surface protein was identified as a molecule that is highly expressed on microvesicles, but not found in HIV-1 virions [ 40 ].”
BackgroundMethodIzquierdo-Useros, N., Blanco, J., Erkizia, I., Fernández-Figueras, M. T., Borràs, F. E., Naranjo-Gómez, M., Bofill, M., Ruiz, L., Clotet, B., & Martinez-Picado, J. (2007) · Journal of Virology · doi:10.1128/jvi.02572-06 · Cited by 108
Cited by
Mathieu, M., Martin-Jaular, L., Lavieu, G., & Théry, C. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0250-9 · Cited by 3,737
Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes
Yáñez-Mó, M., Barreiro, O., Gordon-Alonso, M., Sala-Valdés, M., & Sánchez-Madrid, F. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.06.004 · Cited by 616
Exosomes: Mechanisms of Uptake
McKelvey, K. J., Powell, K. L., Ashton, A. W., Morris, J. M., & McCracken, S. A. (2015) · Journal of Circulating Biomarkers · doi:10.5772/61186 · Cited by 416
Microvesicles and Viral Infection
Meckes, D. G., & Raab-Traub, N. (2011) · Journal of Virology · doi:10.1128/jvi.05853-11 · Cited by 390
CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency
van Zelm, M. C., Smet, J., Adams, B., Mascart, F., Schandené, L., Janssen, F., Ferster, A., Kuo, C.-C., Levy, S., van Dongen, J. J. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39748 · Cited by 381
Metadata
- Authors
- Grigorov, B., Attuil-Audenis, V., Perugi, F., Nedelec, M., Watson, S., Pique, C., Darlix, J.-L., Conjeaud, H., & Muriaux, D.
- Venue
- Retrovirology
- Published
- 2009-03-11
- Volume
- 6
- Issue
- 1
- Pages
- 28-28
- ISSN
- 1742-4690 (ISSN-L)
- OpenAlex
- W2023995363
- Cited by
- 108
- References
- 7
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line. https://app.cochat.ai/papers/10.1186/1742-4690-6-28
- The paper
- Grigorov, B., Attuil-Audenis, V., Perugi, F., Nedelec, M., Watson, S., Pique, C., Darlix, J.-L., Conjeaud, H., & Muriaux, D. (2009). A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line. Retrovirology. https://doi.org/10.1186/1742-4690-6-28
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.